Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05924646
NA

CAlgary SAlt for POTS

Sponsor: University of Calgary

View on ClinicalTrials.gov

Summary

Many patients with postural orthostatic tachycardia syndrome (POTS) have decreased plasma volume. Current POTS guidelines recommend \~10 g of salt and 2-3 L of fluid per day. Despite this recommendation, there is no long term data evaluating the use of salt in POTS. This randomized, placebo-controlled cross-over trial will evaluate a high salt diet, compared to a normal salt diet over a period of 3 months. Participants will complete 3 in lab evaluations including autonomic function testing, tilt table testing, blood volume and urine sodium evaluation, plasma catecholamine measurements and and cytokine measurements.

Official title: CAlgary SAlt for Postural Orthostatic Tachycardia Syndrome Study

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-05-07

Completion Date

2028-12-31

Last Updated

2024-05-10

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Sodium Chloride Capsules

Table salt in slow release capsules.

OTHER

Microcystalline Cellulose Capsules

Microcrystalline Cellulose Capsules (Placebo)

Locations (1)

University of Calgary

Calgary, Alberta, Canada